Coronavirus (Covid-19): Latest updates and information
Skip to main content Skip to navigation

Wellcome Translational Partnership Funding Round 2

Apply for funding

Researchers can face a number of barriers to taking the first step to translating their research, and often need more than financial support, including mentoring and regulatory advice. Together with funding from Wellcome, the Higher Education Fund (HEIF) and the University, the Warwick-Wellcome Translational Partnership (W-WTP) launched in 2020 with the aim to support researchers to make that transition between discovery science and translation.

The W-WTP provides through its suite of programmes, support for translational research projects, fellowships and access to external expertise to overcome well-defined barriers to translation aimed at exploiting emerging impact in the broad areas of science of early life, tissue models of human disease and disease control prevention. This ambitious programme will help to deliver lasting real-world impact from health and biomedical research, whilst strengthening links with partners in industry, clinical settings and government policy makers both nationally and internationally.


Funding Programmes

Two funding programmes are currently available to support people, translational funding and embedding of a biomedical translational research culture:

  • Translation and Innovation Grants to provide project-focussed pump priming awards to support the movement of research ideas along the translational development spectrum and/or move to the next technology readiness level. Applications to buy out UHCW clinician’s time for a translational project would also be welcome. It is anticipated that around 4-5 awards will be made.

  • Breaking Translational Barriers Awards to provide smaller awards of up to £10,000 to access bespoke external expertise and advice on the potential of the idea or technology and overcome well-defined barriers, for example engaging end users and networks, commissioning market research analyses and exploring routes to market to progress their research along the translational pipeline. The Breaking Translational Barriers Awards will not fund Warwick staff time. Contact: Wellcome-Translation at warwick dot ac dot uk to find out more.
     


Eligibility

Both programmes are open to researchers from the Faculties of Science, Engineering and Medicine, Social Sciences and Arts. Applicants should normally be a University academic employee, or be the holder of a personal research fellowship awarded competitively, with a contract lasting the duration of the project. UHCW-employed clinicians are also eligible and applications must provide an accompanying letter from the Clinical Director confirming support for the project. If funding is requested for buy-out time for clinicians a signed letter of support and commitment to the dedicated research time from the Clinical Director is required.


How to Apply

Translation and Innovation Grant applications must be submitted on the Warwick-Wellcome Translational Partnership Application Form to Wellcome-Translation@warwick.ac.uk by 18 January 2021. Please refer to the documents below for full guidance, a copy of the application form and the terms and conditions of the awards.

Documents for application

Please contact Wellcome-Translation at warwick dot ac dot uk to discuss the Breaking Translational Barriers Awards to access bespoke external expertise and advice. A rolling deadline operates for these Awards.

 

Top tips for success

Successful proposals:

  • Explained the context for the proposed work and how it would address a societal, clinical and patient need
  • Described the current position on the translational development pathway and anticipated progress
  • Provided clear plans for future translational and impact activities and funding strategies, and how the proposed work would support these
  • Included sufficient preliminary data and detail, particularly if the proposed activity was reliant on specific technologies or transferable to other drugs or challenges
  • Provided clear and feasible milestones, and deliverables
  • Assembled a strong team comprising the relevant expertise, including relevant external stakeholders
    Offered value for money


Unsuccessful proposals:

  • Were not translational research and more suited to external responsive mode funding schemes
  • Were too early on the translational development pathway to be eligible for the Translational Partnership
  • Were not innovative or other translational and funding routes were more appropriate
  • Did not provide sufficient information on relevant context, e.g. relevant regulation considerations
  • Did not provide sufficient information on the proposed methodologies and evidence of prior success